Company Overview of Progen Pharmaceuticals, Inc.
Progen Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. The company’s products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. As a result of the acquisition of Cellgate, Inc. by Progen Pharmaceuticals Limited, Cellgate's name was changed. The company was founded in 1998 and is based in Palo Alto, California. As of February 7, 2008, Progen Pharmaceuticals, Inc. operates as a subsidiary of Progen Pharmaceuticals Limited.
2479 East Bayshore Road
Palo Alto, CA 94303
Founded in 1998
Key Executives for Progen Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Valley Nuclear Incorporated||United States|
|Allegro Ophthalmics, LLC||United States|
|Foundation Consumer Healthcare, LLC||United States|
|Manhattan Drug Company, Inc.||United States|
|TKCO, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Progen Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.